| scholarly article | Q13442814 |
| P50 | author | Wence Zhou | Q100658311 |
| P2093 | author name string | Liang Qiao | |
| Quan-Bao Zhang | |||
| P2860 | cites work | Micro-RNA profiling in human serum reveals compartment-specific roles of miR-571 and miR-652 in liver cirrhosis | Q21560965 |
| Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study | Q24596256 | ||
| Hereditary hemochromatosis in the post-HFE era | Q24646056 | ||
| Structural and functional aspects of liver sinusoidal endothelial cell fenestrae: a review. | Q24793348 | ||
| IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice | Q27008536 | ||
| Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets | Q28303698 | ||
| Antisense strategy against PDGF B-chain proves effective in preventing experimental liver fibrogenesis | Q28572348 | ||
| Glutathione depletion is involved in the inhibition of procollagen alpha1(I) mRNA levels caused by TNF-alpha on hepatic stellate cells | Q28579226 | ||
| Phyto-power dietary supplement potently inhibits dimethylnitrosamine-induced liver fibrosis in rats | Q85842808 | ||
| Non-invasive tests in prediction of liver fibrosis in chronic hepatitis B and comparison with post-antiviral treatment results | Q86079992 | ||
| Pterostilbene inhibits dimethylnitrosamine-induced liver fibrosis in rats | Q86121244 | ||
| Pro-fibrogenic potential of PDGF-D in liver fibrosis | Q28583234 | ||
| Liver fibrosis | Q29547449 | ||
| Hepatitis B virus infection--natural history and clinical consequences | Q29617961 | ||
| Long-term follow-up of patients with NAFLD and elevated liver enzymes | Q29620024 | ||
| Neuropilin-1 promotes cirrhosis of the rodent and human liver by enhancing PDGF/TGF-beta signaling in hepatic stellate cells | Q30495328 | ||
| Underestimation of liver-related mortality in the United States. | Q30564165 | ||
| Tetrandrine inhibits activation of rat hepatic stellate cells in vitro via transforming growth factor-beta signaling | Q33215337 | ||
| Liver fibrosis causes downregulation of miRNA-150 and miRNA-194 in hepatic stellate cells, and their overexpression causes decreased stellate cell activation | Q33588984 | ||
| The progression of liver fibrosis is related with overexpression of the miR-199 and 200 families | Q33808955 | ||
| The morphology of cirrhosis. Recommendations on definition, nomenclature, and classification by a working group sponsored by the World Health Organization | Q33846319 | ||
| Natural history of hepatitis C: its impact on clinical management | Q33873345 | ||
| Liver pathology: cirrhosis, hepatitis, and primary liver tumors. Update and diagnostic problems | Q33955384 | ||
| Cooperation of liver cells in health and disease | Q34103771 | ||
| The use of silymarin in the treatment of liver diseases | Q34104302 | ||
| Hepatic steatosis, low-grade chronic inflammation and hormone/growth factor/adipokine imbalance | Q34200821 | ||
| Non-invasive assessment of changes in liver fibrosis via liver stiffness measurement in patients with chronic hepatitis B: impact of antiviral treatment on fibrosis regression | Q34365464 | ||
| Hepatic stellate cells as a target for the treatment of liver fibrosis | Q34391409 | ||
| Activation of cultured rat hepatic lipocytes by Kupffer cell conditioned medium. Direct enhancement of matrix synthesis and stimulation of cell proliferation via induction of platelet-derived growth factor receptors | Q34580643 | ||
| PDGF and signal transduction in hepatic stellate cells | Q34754831 | ||
| Update on viral hepatitis: 2007. | Q34769655 | ||
| Innate immunity and primary biliary cirrhosis: activated invariant natural killer T cells exacerbate murine autoimmune cholangitis and fibrosis | Q34790985 | ||
| Hepatic fibrosis--role of hepatic stellate cell activation | Q35017363 | ||
| Preventive effect of halofuginone on concanavalin A-induced liver fibrosis | Q35072681 | ||
| Hepatitis C and liver fibrosis | Q35091476 | ||
| Lack of interleukin-1α or interleukin-1β inhibits transformation of steatosis to steatohepatitis and liver fibrosis in hypercholesterolemic mice | Q35535851 | ||
| Th2-associated alternative Kupffer cell activation promotes liver fibrosis without inducing local inflammation | Q35565153 | ||
| Arsenic stimulates sinusoidal endothelial cell capillarization and vessel remodeling in mouse liver | Q35575155 | ||
| Chinese medicines as a resource for liver fibrosis treatment | Q35575460 | ||
| Pegylated interferon-alpha plus taurine in treatment of rat liver fibrosis | Q35621270 | ||
| Serum Bcl-2 concentrations in overweight-obese subjects with nonalcoholic fatty liver disease | Q35638789 | ||
| Tumour necrosis factor alpha signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice | Q35760220 | ||
| Effect of rat serum containing Biejiajian oral liquid on proliferation of rat hepatic stellate cells | Q36065884 | ||
| Interleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis in mice | Q36089631 | ||
| Establishment of an early liver fibrosis model by the hydrodynamics-based transfer of TGF-beta1 gene | Q36183787 | ||
| The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis | Q36253127 | ||
| Therapeutic effect of interleukin-10 on CCl4-induced hepatic fibrosis in rats | Q42774193 | ||
| Inhibitory effect of human interferon‐beta‐1a on activated rat and human hepatic stellate cells | Q42840326 | ||
| Anti‐PDGF‐B monoclonal antibody reduces liver fibrosis development | Q42873669 | ||
| Hepatic and serum levels of miR-122 after chronic HCV-induced fibrosis | Q42985352 | ||
| Serum transforming growth factor-beta1(TGF-beta1) in patients with cirrhosis, chronic hepatitis B and chronic hepatitis C [corrected]. | Q42987012 | ||
| Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: a pilot trial of interferon nonresponders | Q42997948 | ||
| Antifibrotic and fibrolytic properties of celecoxib in liver damage induced by carbon tetrachloride in the rat. | Q43044113 | ||
| S-nitroso-N-acetylcysteine attenuates liver fibrosis in experimental nonalcoholic steatohepatitis. | Q43105330 | ||
| Efficacy of Chinese medicine Yi-gan-kang granule in prophylaxis and treatment of liver fibrosis in rats | Q43118525 | ||
| Therapeutic effects of hepatocyte growth factor-overexpressing human umbilical cord blood-derived mesenchymal stem cells on liver fibrosis in rats. | Q43608224 | ||
| Could inflammatory markers help diagnose nonalcoholic steatohepatitis? | Q43638783 | ||
| Platelet-derived growth factor (PDGF)-C neutralization reveals differential roles of PDGF receptors in liver and kidney fibrosis | Q43801941 | ||
| Pioglitazone prevents hepatic steatosis, fibrosis, and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet | Q44794876 | ||
| The antifibrotic effects of TGF-β1 siRNA on hepatic fibrosis in rats | Q45021647 | ||
| Targeted glycyrrhetinic acid to receptors of hepatic stellate cells for the treatment of rat liver fibrosis: a pilot study | Q45030329 | ||
| Hypoxia potentiates transforming growth factor-beta expression of hepatocyte during the cirrhotic condition in rat liver | Q45164446 | ||
| Relation between hepatocyte G1 arrest, impaired hepatic regeneration, and fibrosis in chronic hepatitis C virus infection | Q45212238 | ||
| Inhibition of inhibitor of kappaB kinases stimulates hepatic stellate cell apoptosis and accelerated recovery from rat liver fibrosis. | Q45212249 | ||
| Quantifying the fraction of cirrhosis attributable to alcohol among chronic hepatitis C virus patients: implications for treatment cost-effectiveness. | Q45354911 | ||
| miR-133a mediates TGF-β-dependent derepression of collagen synthesis in hepatic stellate cells during liver fibrosis | Q45749834 | ||
| Efficacy of HGF carried by ultrasound microbubble-cationic nano-liposomes complex for treating hepatic fibrosis in a bile duct ligation rat model, and its relationship with the diffusion-weighted MRI parameters | Q45856368 | ||
| Electroporative interleukin-10 gene transfer ameliorates carbon tetrachloride-induced murine liver fibrosis by MMP and TIMP modulation | Q45856745 | ||
| The treatment of liver fibrosis induced by hepatocyte growth factor-directed, ultrasound-targeted microbubble destruction in rats | Q45889224 | ||
| Liver cirrhosis in Malaysia: peculiar epidemiology in a multiracial Asian country. | Q45905963 | ||
| Post-treatment of Ganoderma lucidum reduced liver fibrosis induced by thioacetamide in mice. | Q45924273 | ||
| Improvement in dissolution of liver fibrosis in an animal model by tetrathiomolybdate | Q46078181 | ||
| Platelet-activating factor involvement in thioacetamide-induced experimental liver fibrosis and cirrhosis | Q46109477 | ||
| Mouse model of primary biliary cirrhosis with progressive fibrosis: are we there yet? | Q46186395 | ||
| Development of a new animal model of liver cirrhosis in swine | Q46262034 | ||
| Long-term treatment of bile duct-ligated rats with rapamycin (sirolimus) significantly attenuates liver fibrosis: analysis of the underlying mechanisms | Q46381192 | ||
| Impact of immunosuppressive treatment on liver fibrosis in autoimmune hepatitis | Q46422178 | ||
| Spontaneous hepatic fibrosis in transgenic mice overexpressing PDGF-A. | Q46503899 | ||
| Antifibrotic effects of interleukin-10 on experimental hepatic fibrosis. | Q46771179 | ||
| Hepatocyte production of modulators of extracellular liver matrix in normal and cirrhotic rat liver. | Q46839182 | ||
| The treatment with antibody of TNF-alpha reduces the inflammation, necrosis and fibrosis in the non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet | Q46860893 | ||
| Autocrine release of TGF-beta by portal fibroblasts regulates cell growth | Q47208152 | ||
| IGF-I induces DNA synthesis and apoptosis in rat liver hepatic stellate cells (HSC) but DNA synthesis and proliferation in rat liver myofibroblasts (rMF). | Q47446541 | ||
| Dominant-negative soluble PDGF-beta receptor inhibits hepatic stellate cell activation and attenuates liver fibrosis | Q47785420 | ||
| The effect of taurine treatment on oxidative stress in experimental liver fibrosis | Q47892617 | ||
| Salvianolic acid B inhibits hepatic stellate cell activation through transforming growth factor beta-1 signal transduction pathway in vivo and in vitro. | Q50486496 | ||
| Reversibility of liver fibrosis and cirrhosis following treatment for hepatitis C. | Q50584678 | ||
| Treating iron overload. | Q50916066 | ||
| Interleukin-17A plays a pivotal role in cholestatic liver fibrosis in mice. | Q51073781 | ||
| Osteopontin induces ductular reaction contributing to liver fibrosis. | Q53068016 | ||
| Liver specific deletion of CYLDexon7/8 induces severe biliary damage, fibrosis and increases hepatocarcinogenesis in mice. | Q53268792 | ||
| An inhibitor of cyclin-dependent kinase, stress-induced p21Waf-1/Cip-1, mediates hepatocyte mito-inhibition during the evolution of cirrhosis. | Q53358254 | ||
| Probucol attenuates ethanol-induced liver fibrosis in rats by inhibiting oxidative stress, extracellular matrix protein accumulation and cytokine production. | Q54239987 | ||
| MicroRNA-221/222 upregulation indicates the activation of stellate cells and the progression of liver fibrosis. | Q54327847 | ||
| Excess iron modulates endoplasmic reticulum stress-associated pathways in a mouse model of alcohol and high-fat diet-induced liver injury. | Q54402929 | ||
| Inhibitory effect of antisense oligonucleotide targeting TIMP-2 on immune-induced liver fibrosis. | Q54478097 | ||
| Octreotide modulates the effects on fibrosis of TNF-α, TGF-β and PDGF in activated rat hepatic stellate cells. | Q54511632 | ||
| α-Lipoic acid inhibits liver fibrosis through the attenuation of ROS-triggered signaling in hepatic stellate cells activated by PDGF and TGF-β. | Q39605106 | ||
| Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis | Q39953406 | ||
| The therapeutic potential of human umbilical mesenchymal stem cells from Wharton's jelly in the treatment of rat liver fibrosis | Q39984252 | ||
| Ribavirin and mycophenolic acid markedly potentiate the anti-hepatitis B virus activity of entecavir | Q40209514 | ||
| Antifibrotic effects of Salvia miltiorrhiza on dimethylnitrosamine-intoxicated rats | Q40428414 | ||
| Activated stellate cells express the TRAIL receptor-2/death receptor-5 and undergo TRAIL-mediated apoptosis. | Q40681279 | ||
| Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies | Q40911465 | ||
| Hepatic sinusoidal endothelial cell in alcoholemia and endotoxemia | Q40937686 | ||
| Stimulation of hepatic lipocyte collagen production by Kupffer cell-derived transforming growth factor beta: implication for a pathogenetic role in alcoholic liver fibrogenesis | Q41228197 | ||
| Dysregulated bile acid synthesis, metabolism and excretion in a high fat-cholesterol diet-induced fibrotic steatohepatitis in rats. | Q41773496 | ||
| Effect of natural interferon α on proliferation and apoptosis of hepatic stellate cells | Q42036156 | ||
| Effect of Chinese medicine Qinggan Huoxuefang on inducing HSC apoptosis in alcoholic liver fibrosis rats | Q42062485 | ||
| Treatment of pig serum-induced rat liver fibrosis with Boschniakia rossica, oxymatrine and interferon-alpha | Q42135582 | ||
| Inhibitory effects of microRNA 19b in hepatic stellate cell-mediated fibrogenesis | Q42144833 | ||
| Sensitization of hepatic lipocytes by high-fat diet to stimulatory effects of Kupffer cell-derived factors: implication in alcoholic liver fibrogenesis | Q42483727 | ||
| Capillarization and venularization of hepatic sinusoids in porcine serum-induced rat liver fibrosis: A mechanism to maintain liver blood flow | Q42484022 | ||
| Autoimmune Hepatitis or Wilson's Disease, a Clinical Dilemma | Q42536152 | ||
| Role of Kupffer cells in the pathogenesis of liver disease | Q42726018 | ||
| [Model establishment of liver fibrosis in oral arsenic solution exposed mice] | Q84970908 | ||
| Clinical observation of salvianolic acid B in treatment of liver fibrosis in chronic hepatitis B. | Q36308206 | ||
| Therapeutic strategies against TGF-beta signaling pathway in hepatic fibrosis | Q36371664 | ||
| Expression of interleukin-17 associated with disease progression and liver fibrosis with hepatitis B virus infection: IL-17 in HBV infection | Q36687453 | ||
| Role of differentiation of liver sinusoidal endothelial cells in progression and regression of hepatic fibrosis in rats | Q36746393 | ||
| Mesenchymal stem cells and Interleukin-6 attenuate liver fibrosis in mice | Q36794471 | ||
| Traditional Chinese herbal medicines for treatment of liver fibrosis and cancer: from laboratory discovery to clinical evaluation. | Q36909491 | ||
| Gene modulation for treating liver fibrosis | Q36921638 | ||
| Efficacy of combined therapy in patients with hepatitis B virus-related decompensated cirrhosis | Q36932092 | ||
| Melatonin ameliorates experimental hepatic fibrosis induced by carbon tetrachloride in rats | Q37158649 | ||
| Ursodeoxycholic acid treatment improves hepatocyte ultrastructure in rat liver fibrosis | Q37209950 | ||
| 3,3'-Diindolylmethane ameliorates experimental hepatic fibrosis via inhibiting miR-21 expression. | Q37219104 | ||
| Sinusoidal endothelial cells prevent rat stellate cell activation and promote reversion to quiescence | Q37224985 | ||
| Interleukin-1 participates in the progression from liver injury to fibrosis | Q37231308 | ||
| Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update | Q37278241 | ||
| Interleukin-33 overexpression is associated with liver fibrosis in mice and humans. | Q37311036 | ||
| Fibrosis and cirrhosis reversibility - molecular mechanisms | Q37317650 | ||
| In liver fibrosis, dendritic cells govern hepatic inflammation in mice via TNF-alpha | Q37403094 | ||
| Impact of interferon-alpha treatment on liver fibrosis in patients with chronic hepatitis B: an overview of published trials | Q37565848 | ||
| Vascular endothelial growth factor promotes fibrosis resolution and repair in mice | Q37726957 | ||
| IL-6: from its discovery to clinical applications | Q37735571 | ||
| Recent advances in liver sinusoidal endothelial ultrastructure and fine structure immunocytochemistry. | Q37929997 | ||
| Fuzheng huayu capsule in the treatment of liver fibrosis: clinical evidence and mechanism of action | Q37995977 | ||
| The potential of microRNAs in liver fibrosis | Q38033924 | ||
| Review article: the reversibility of cirrhosis | Q38042443 | ||
| Progression of liver fibrosis in post-transplant hepatitis C: mechanisms, assessment and treatment | Q38069395 | ||
| A new strategy for treatment of liver fibrosis: letting MicroRNAs do the job. | Q38074884 | ||
| Status and prospects of liver cirrhosis treatment by using bone marrow-derived cells and mesenchymal cells | Q38180802 | ||
| Progelatinase A is produced and activated by rat hepatic stellate cells and promotes their proliferation | Q38320182 | ||
| Prevention of CCl4-induced liver cirrhosis by ribbon antisense to transforming growth factor-beta1. | Q38502948 | ||
| Aryl hydrocarbon receptor-dependent induction of liver fibrosis by dioxin | Q39072337 | ||
| Efficacy and safety of tauroursodeoxycholic acid in the treatment of liver cirrhosis: a double-blind randomized controlled trial | Q39228975 | ||
| Induction of microRNA-214-5p in human and rodent liver fibrosis | Q39304895 | ||
| Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice | Q39333394 | ||
| Houttuynia cordata inhibits lipopolysaccharide-induced rapid pulmonary fibrosis by up-regulating IFN-γ and inhibiting the TGF-β1/Smad pathway | Q39353206 | ||
| miR-181b promotes hepatic stellate cells proliferation by targeting p27 and is elevated in the serum of cirrhosis patients | Q39374420 | ||
| Primary biliary cirrhosis | Q56428272 | ||
| Hepatocyte Apoptosis, Expression of Death Receptors, and Activation of NF-κB in the Liver of Nonalcoholic and Alcoholic Steatohepatitis Patients | Q57760193 | ||
| Targeted delivery of a novel group of site-directed transglutaminase inhibitors to the liver using liposomes: a new approach for the potential treatment of liver fibrosis | Q57937571 | ||
| Inhibition by curcumin of diethylnitrosamine-induced hepatic hyperplasia, inflammation, cellular gene products and cell-cycle-related proteins in rats | Q58215294 | ||
| Increased toxin-induced liver injury and fibrosis in interleukin-6-deficient mice | Q58535662 | ||
| Circulating levels of cytochrome C, gamma-glutamyl transferase, triglycerides and unconjugated bilirubin in overweight/obese patients with non-alcoholic fatty liver disease | Q62221978 | ||
| Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis | Q63384204 | ||
| Inhibitory effect of a soluble transforming growth factor β type II receptor on the activation of rat hepatic stellate cells in primary culture | Q64377369 | ||
| Assessment of Kupffer cell function in rats with chronic liver injury caused by CCl4 | Q68859936 | ||
| Something new in liver cirrhosis epidemiology | Q69372721 | ||
| [Animals with liver fibrosis induced by albumin immunization] | Q69455754 | ||
| Defenestration of the sinusoidal endothelial cell in a rat model of cirrhosis | Q70710423 | ||
| Role of sinusoidal endothelial cells in liver disease | Q70971781 | ||
| Interferon gamma decreases hepatic stellate cell activation and extracellular matrix deposition in rat liver fibrosis | Q71057954 | ||
| An electron microscopic study of the fenestrated endothelial lining of rat liver sinusoids | Q71500865 | ||
| Genetic hemochromatosis and Wilson's disease: role for oxidant stress? | Q72131212 | ||
| Kupffer cell iron overload induces intercellular adhesion molecule-1 expression on hepatocytes in genetic hemochromatosis | Q72210555 | ||
| An interleukin-1 receptor antagonist decreases fibrosis induced by dimethylnitrosamine in rat liver | Q72861100 | ||
| Regression of human cirrhosis. Morphologic features and the genesis of incomplete septal cirrhosis | Q73191758 | ||
| Alcohol-induced sinusoidal endothelial cell dysfunction in the mouse is associated with exacerbated liver apoptosis and can be reversed by caspase inhibition | Q73343476 | ||
| Studies on hepatocyte apoptosis, proliferation and oncogene c-fos expression in carbon tetrachloride-induced cirrhotic rat liver | Q73611340 | ||
| Development of an animal model of hepatic fibrosis by excretory-secretory antigen of Ascaris suum | Q74083752 | ||
| Alcohol consumption induces hepatocyte apoptosis in patients with chronic hepatitis C infection | Q74151275 | ||
| Plasma leptin and TNF-alpha levels in chronic hepatitis C patients and their relationship to hepatic fibrosis | Q74522669 | ||
| The bcl, NFkappaB and p53/p21WAF1 systems are involved in spontaneous apoptosis and in the anti-apoptotic effect of TGF-beta or TNF-alpha on activated hepatic stellate cells | Q74525413 | ||
| Inhibitory effect of glycyrrhizin on NF-kappaB binding activity in CCl4- plus ethanol-induced liver cirrhosis in rats | Q77144220 | ||
| Microvascular consequences of Kupffer cell modulation in rat liver fibrogenesis | Q78140646 | ||
| Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression | Q79209033 | ||
| Low-dose oral rapamycin treatment reduces fibrogenesis, improves liver function, and prolongs survival in rats with established liver cirrhosis | Q79269840 | ||
| Protective effect of verapamil on multiple hepatotoxic factors-induced liver fibrosis in rats | Q79559623 | ||
| Development of autoimmune hepatitis in patients with typical primary biliary cirrhosis | Q79788278 | ||
| Liver fibrosis induced by hepatic overexpression of PDGF-B in transgenic mice | Q79912489 | ||
| Depression in patients with primary biliary cirrhosis and primary sclerosing cholangitis | Q80073128 | ||
| Effect of losartan on early liver fibrosis development in a rat model of nonalcoholic steatohepatitis | Q80470886 | ||
| Kupffer cell activation in normal and fibrotic livers increases portal pressure via thromboxane A(2) | Q80487409 | ||
| Interferon-gamma acts proapoptotic on hepatic stellate cells (HSC) and abrogates the antiapoptotic effect of interferon-alpha by an HSP70-dependant pathway | Q80994283 | ||
| [Epidemiology and natural history of cirrhosis] | Q81413720 | ||
| Treatment strategy for liver fibrosis through recruitment and differentiation of bone marrow stem/progenitor cells | Q81537344 | ||
| Vitamin E reduces hepatic fibrosis in mice with Schistosoma japonicum infection | Q82336816 | ||
| Hepatoprotection of silymarin against thioacetamide-induced chronic liver fibrosis | Q82604112 | ||
| HGF inhibits TGF-β1-induced myofibroblast differentiation and ECM deposition via MMP-2 in Achilles tendon in rat | Q82928049 | ||
| Colchicine treatment of liver fibrosis | Q83141208 | ||
| Inhibition of connective tissue growth factor by siRNA prevents liver fibrosis in rats | Q83230807 | ||
| Screening for Wilson's disease in acute liver failure: a comparison of currently available diagnostic tests | Q83586436 | ||
| Targeted delivery of drugs for liver fibrosis | Q83766456 | ||
| Target specific systemic delivery of TGF-β siRNA/(PEI-SS)-g-HA complex for the treatment of liver cirrhosis | Q83826798 | ||
| Increased hepatic fibrosis and JNK2-dependent liver injury in mice exhibiting hepatocyte-specific deletion of cFLIP | Q84382913 | ||
| Rat liver sinusoidal endothelial cells (LSECs) express functional low density lipoprotein receptor-related protein-1 (LRP-1) | Q84441171 | ||
| P433 | issue | 23 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | liver cirrhosis | Q147778 |
| pathogenesis | Q372016 | ||
| P304 | page(s) | 7312-7324 | |
| P577 | publication date | 2014-06-01 | |
| P1433 | published in | World Journal of Gastroenterology | Q15708885 |
| P1476 | title | Pathogenesis of liver cirrhosis | |
| P478 | volume | 20 |
| Q55387853 | A New Intelligent Medical Decision Support System Based on Enhanced Hierarchical Clustering and Random Decision Forest for the Classification of Alcoholic Liver Damage, Primary Hepatoma, Liver Cirrhosis, and Cholelithiasis. |
| Q64982772 | A proteomic approach of biomarker candidate discovery for alcoholic liver cirrhosis. |
| Q89661742 | Accuracy of real-time shear wave elastography in staging hepatic fibrosis: a meta-analysis |
| Q92865156 | An integrative method to predict signalling perturbations for cellular transitions |
| Q89250918 | Angiogenesis and Hepatic Fibrosis: Western and Chinese Medicine Therapies on the Road |
| Q47237512 | BMP Signalling at the Crossroad of Liver Fibrosis and Regeneration. |
| Q90224956 | Beneficial and Deleterious Effects of Female Sex Hormones, Oral Contraceptives, and Phytoestrogens by Immunomodulation on the Liver |
| Q38919351 | Bisdemethoxycurcumin Induces apoptosis in activated hepatic stellate cells via cannabinoid receptor 2. |
| Q64102673 | Blood-Bile Barrier: Morphology, Regulation, and Pathophysiology |
| Q41191069 | Bone marrow-derived monocyte infusion improves hepatic fibrosis by decreasing osteopontin, TGF-β1, IL-13 and oxidative stress |
| Q57066901 | Candidate Biomarkers of Liver Fibrosis: A Concise, Pathophysiology-oriented Review |
| Q57807125 | Carcinogenesis on the background of liver fibrosis: Implications for the management of hepatocellular cancer |
| Q89834694 | Cellular Interplay as a Consequence of Inflammatory Signals Leading to Liver Fibrosis Development |
| Q47147587 | Circulating miR-210 and miR-22 combined with ALT predict the virological response to interferon-alpha therapy of CHB patients |
| Q55008681 | Cirrhosis of liver: Interference of serpins in quantification of SERPINA4 - A preliminary study. |
| Q41650209 | Cirrhotic Cardiomyopathy: Another Case of a Successful Approach to Treatment of Hepatorenal Syndrome |
| Q60920560 | Current therapies and novel approaches for biliary diseases |
| Q47104873 | Cytokines, hepatic cell profiling and cell interactions during bone marrow cell therapy for liver fibrosis in cholestatic mice |
| Q35375422 | Early activated hepatic stellate cell-derived molecules reverse acute hepatic injury |
| Q90227288 | Effect of Hepatitis Viruses on the Nrf2/Keap1-Signaling Pathway and Its Impact on Viral Replication and Pathogenesis |
| Q47169192 | Effects of calcium Ionophore A23187 on the apoptosis of hepatic stellate cells stimulated by transforming growth factor-β1. |
| Q54447129 | Effects of lactulose and silymarin on liver enzymes in cirrhotic rats. |
| Q39408379 | Effects of tanshinone IIA on fibrosis in a rat model of cirrhosis through heme oxygenase-1, inflammation, oxidative stress and apoptosis |
| Q90733835 | Enhanced hepatic differentiation in the subpopulation of human amniotic stem cells under 3D multicellular microenvironment |
| Q92290311 | Estrogen Deficiency Potentiates Thioacetamide-Induced Hepatic Fibrosis in Sprague-Dawley Rats |
| Q35759086 | Evidence of Active Pro-Fibrotic Response in Blood of Patients with Cirrhosis |
| Q90722857 | Gas6/TAM System: A Key Modulator of the Interplay between Inflammation and Fibrosis |
| Q55261033 | Genetic polymorphisms in ataxin-3 and liver cirrhosis risk related to aflatoxin B1. |
| Q47548530 | Genetic variants of interferon regulatory factor 5 associated with chronic hepatitis B infection |
| Q26778035 | Genetic, metabolic and environmental factors involved in the development of liver cirrhosis in Mexico |
| Q88458017 | Hepatic Encephalopathy in Liver Cirrhosis |
| Q26752622 | Hepatoprotective Effects of Chinese Medicinal Herbs: A Focus on Anti-Inflammatory and Anti-Oxidative Activities |
| Q64275574 | High Risk of Hepatocellular Carcinoma Development in Fibrotic Liver: Role of the Hippo-YAP/TAZ Signaling Pathway |
| Q64901322 | Hypoxia signaling in human diseases and therapeutic targets. |
| Q41200837 | Identification of key metabolic changes during liver fibrosis progression in rats using a urine and serum metabolomics approach |
| Q54938916 | Influence of spontaneous splenorenal shunts on clinical outcomes in decompensated cirrhosis and after liver transplantation. |
| Q49160532 | Isotopic analysis of Cu in blood serum by multi-collector ICP-mass spectrometry: a new approach for the diagnosis and prognosis of liver cirrhosis? |
| Q91707152 | Liver Cirrhosis Patients Who Had Normal Liver Function Before Liver Cirrhosis Development Have the Altered Metabolic Profiles Before the Disease Occurrence Compared to Healthy Controls |
| Q38934348 | Liver diseases: what is known so far about the therapy with human amniotic membrane? |
| Q49343963 | Liver fibrosis detection and staging: a comparative study of T1ρ MR imaging and 2D real-time shear-wave elastography |
| Q47122280 | Liver fibrosis: a compilation on the biomarkers status and their significance during disease progression |
| Q60950165 | Liver-Derived Exosomes and Their Implications in Liver Pathobiology |
| Q64983790 | Long-chain fatty acid activates hepatocytes through CD36 mediated oxidative stress. |
| Q90734179 | Melatonin Ameliorates Liver Fibrosis Induced by Carbon Tetrachloride in Rats via Inhibiting TGF-β1/Smad Signaling Pathway |
| Q98944107 | Mesenchymal stem cell-based cell-free strategies: safe and effective treatments for liver injury |
| Q45069266 | Microbiota, cirrhosis, and the emerging oral-gut-liver axis |
| Q38684604 | Molecular interplays in hepatic stellate cells: apoptosis, senescence, and phenotype reversion as cellular connections that modulate liver fibrosis |
| Q57119171 | Molecular magnetic resonance imaging accurately measures the antifibrotic effect of EDP-305, a novel farnesoid X receptor agonist |
| Q91991242 | Myofibroblast-specific YY1 promotes liver fibrosis |
| Q42364467 | Nanoparticles for the treatment of liver fibrosis |
| Q89630010 | Neovascularization is a key feature of liver fibrosis progression: anti-angiogenesis as an innovative way of liver fibrosis treatment |
| Q92542959 | Next-Generation Liver Medicine Using Organoid Models |
| Q93346016 | Non-Hepatic Abdominal Surgery in Patients with Cirrhotic Liver Disease |
| Q60959532 | Oral Dysbiosis in Pancreatic Cancer and Liver Cirrhosis: A Review of the Literature |
| Q38651670 | Overt Hepatic Encephalopathy Experienced by Individuals With Cirrhosis: A Qualitative Interview Study. |
| Q26773384 | Oxidative Stress and Inflammation in Hepatic Diseases: Therapeutic Possibilities of N-Acetylcysteine |
| Q90599251 | Palmitoylethanolamide Ameliorates Carbon Tetrachloride-Induced Liver Fibrosis in Rats |
| Q47140147 | Pathological process of liver sinusoidal endothelial cells in liver diseases |
| Q91729549 | Plasma microRNA: A novel non-invasive biomarker for HBV-associated liver fibrosis staging |
| Q40917613 | Plumbagin Ameliorates CCl 4 -Induced Hepatic Fibrosis in Rats via the Epidermal Growth Factor Receptor Signaling Pathway |
| Q58740610 | Prognostic significance of vitamin D receptor (VDR) gene polymorphisms in liver cirrhosis |
| Q98181430 | Prognostic value of tumor stromal collagen features in patients with hepatocellular carcinoma revealed by second-harmonic generation microscopy |
| Q37358974 | Protective Effects of Adenosine Receptor Agonist in a Cirrhotic Liver Resection Model |
| Q93052927 | Protective role of melatonin in early-stage and end-stage liver cirrhosis |
| Q92504942 | Role of Granulocyte Colony-stimulating Factor Therapy in Cirrhosis, 'Inside Any Deep Asking Is the Answering' |
| Q92816778 | Rotavirus Reassortant-Induced Murine Model of Liver Fibrosis Parallels Human Biliary Atresia |
| Q55408871 | Salidroside ameliorates autophagy and activation of hepatic stellate cells in mice via NF-κB and TGF-β1/Smad3 pathways. |
| Q41591361 | Sedum mexicanum Britt. Induces Apoptosis of Primary Rat Activated Hepatic Stellate Cells |
| Q40852299 | Selected Noninvasive Markers in Diagnosing Liver Diseases |
| Q57027234 | Small intestinal bacterial overgrowth in cirrhosis: systematic review and meta-analysis |
| Q48275993 | The Outcome of Thoracentesis versus Chest Tube Placement for Hepatic Hydrothorax in Patients with Cirrhosis: A Nationwide Analysis of the National Inpatient Sample. |
| Q55415931 | The Role of Cannabinoids in the Setting of Cirrhosis. |
| Q46407865 | The antifibrogenic effect of etanercept on development of liver cirrhosis induced by thioacetamide in rats. |
| Q98466000 | The effects of concurrent treatment of silymarin and lactulose on memory changes in cirrhotic male rats |
| Q45324860 | The neglected avian hepatotropic virus induces acute and chronic hepatitis in ducks: an alternative model for hepatology |
| Q59789235 | Therapeutic effect of hepatocyte growth factor-overexpressing bone marrow-derived mesenchymal stem cells on CCl-induced hepatocirrhosis |
| Q26749460 | Thrombin activation and liver inflammation in advanced hepatitis C virus infection |
| Q95300471 | Transplantation of fetal liver tissue coated by ultra-purified alginate gel over liver improves hepatic function in the cirrhosis rat model |
| Q26799273 | Understanding the Complexities of Cirrhosis |
| Q52987411 | [Modern magnetic resonance imaging of the liver]. |
Search more.